ADVERTISEMENT

Tatva Chintan Q4 Results Review - Revenue May Rise 25% With Expansion In Margin: ICICI Securities

Gross profit margin up 215 bps QoQ to 57.8%

<div class="paragraphs"><p>Tatva Chintan Pharma Chem Ltd.(Source: Company)</p></div>
Tatva Chintan Pharma Chem Ltd.(Source: Company)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to Unlock & Enjoy your 
Subscriber-Only
 benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More